357 related articles for article (PubMed ID: 6245108)
1. Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection.
Catalano MA; Carson DA; Niederman JC; Feorino P; Vaughan JH
J Clin Invest; 1980 May; 65(5):1238-42. PubMed ID: 6245108
[TBL] [Abstract][Full Text] [Related]
2. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis.
Catalano MA; Carson DA; Slovin SF; Richman DD; Vaughan JH
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5825-8. PubMed ID: 230491
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus and rheumatoid arthritis: are rheumatoid arthritis associated nuclear antigen and Epstein-Barr virus nuclear antigen different?
Cohen JH; Lenoir GM
Biomed Pharmacother; 1982; 36(5):246-9. PubMed ID: 6301567
[TBL] [Abstract][Full Text] [Related]
5. [Is there a relationship between Epstein-Barr virus and rheumatoid arthritis (author's transl)].
Lemaire V
Nouv Presse Med; 1982 May; 11(25):1945-7. PubMed ID: 6287408
[TBL] [Abstract][Full Text] [Related]
6. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
7. [Epstein-Barr virus and infectious mononucleosis. A clinical study of Epstein-Barr antibodies (author's transl)].
Seigneurin JM; Kressmann MC; Lavoué MF; Saez G; Lenoir G
Nouv Presse Med; 1978 Dec; 7(44):4005-10. PubMed ID: 215969
[TBL] [Abstract][Full Text] [Related]
8. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
Fark AR
J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641
[TBL] [Abstract][Full Text] [Related]
9. Lack of relationship between the Epstein-Barr virus and the antiperinuclear factor/'perinuclear antigen' system in rheumatoid arthritis.
Buisson M; Berthelot JM; Le Goff P; Chastel C; Lamour A; Seigneurin JM; Youinou P
J Autoimmun; 1994 Aug; 7(4):485-95. PubMed ID: 7980850
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of viral capsid anti-antigen antibodies of the Epstein Barr virus in infectious mononucleosis. Comparative evaluation of a fluorescence method with classic methods].
Picerno G; Lari M; Fregoso F; Musmanno G
Quad Sclavo Diagn; 1983 Dec; 19(4):489-98. PubMed ID: 6330785
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
[TBL] [Abstract][Full Text] [Related]
12. Antiperinuclear factor, a rheumatoid arthritis specific autoantibody: its relation to Epstein-Barr virus.
Westgeest AA; van Loon AM; van der Logt JT; van de Putte LB; Boerbooms AM
J Rheumatol; 1989 May; 16(5):626-30. PubMed ID: 2547060
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
14. [Epstein-Barr virus infection in children: study of infectious mononucleosis without heterophil antibodies].
Baccard C; François P; Bost M; Bachelot C; Decret M; Beaudoing A; Seigneurin JM
Ann Pediatr (Paris); 1983 Jun; 30(6):416-21. PubMed ID: 6309061
[No Abstract] [Full Text] [Related]
15. Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen.
Rhodes G; Carson DA; Valbracht J; Houghten R; Vaughan JH
J Immunol; 1985 Jan; 134(1):211-6. PubMed ID: 2981091
[TBL] [Abstract][Full Text] [Related]
16. Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis.
Ferrell PB; Aitcheson CT; Pearson GR; Tan EM
J Clin Invest; 1981 Mar; 67(3):681-7. PubMed ID: 6259207
[TBL] [Abstract][Full Text] [Related]
17. [Rheumatoid arthritis associated nuclear antigen (RANA) and Epstein-Barr virus (EBV)].
Li ZG
Zhonghua Yi Xue Za Zhi; 1988 Aug; 68(8):447-9, 32. PubMed ID: 2852534
[No Abstract] [Full Text] [Related]
18. High titer of antibody to the Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus.
Yokochi T; Yanagawa A; Kimura Y; Mizushima Y
J Rheumatol; 1989 Aug; 16(8):1029-32. PubMed ID: 2555505
[TBL] [Abstract][Full Text] [Related]
19. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis.
Pratesi F; Tommasi C; Anzilotti C; Chimenti D; Migliorini P
Arthritis Rheum; 2006 Mar; 54(3):733-41. PubMed ID: 16508937
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera.
Kouri T; Petersen J; Rhodes G; Aho K; Palosuo T; Heliövaara M; Isomäki H; von Essen R; Vaughan JH
J Rheumatol; 1990 Nov; 17(11):1442-9. PubMed ID: 2177109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]